These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Insight into k13-propeller gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates. Menard S; Tchoufack JN; Maffo CN; Nsango SE; Iriart X; Abate L; Tsapi MT; Awono-Ambéné PH; Abega Mekongo FA; Morlais I; Berry A Malar J; 2016 Nov; 15(1):572. PubMed ID: 27887614 [TBL] [Abstract][Full Text] [Related]
24. Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria. Intharabut B; Kingston HW; Srinamon K; Ashley EA; Imwong M; Dhorda M; Woodrow C; Stepniewska K; Silamut K; Day NPJ; Dondorp AM; White NJ; J Infect Dis; 2019 Apr; 219(9):1483-1489. PubMed ID: 30657916 [TBL] [Abstract][Full Text] [Related]
25. Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal. Madamet M; Kounta MB; Wade KA; Lo G; Diawara S; Fall M; Bercion R; Nakoulima A; Fall KB; Benoit N; Gueye MW; Fall B; Diatta B; Pradines B Int J Antimicrob Agents; 2017 Jun; 49(6):754-756. PubMed ID: 28450175 [TBL] [Abstract][Full Text] [Related]
26. Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy. Huang B; Deng C; Yang T; Xue L; Wang Q; Huang S; Su XZ; Liu Y; Zheng S; Guan Y; Xu Q; Zhou J; Yuan J; Bacar A; Abdallah KS; Attoumane R; Mliva AM; Zhong Y; Lu F; Song J Parasit Vectors; 2015 Dec; 8():634. PubMed ID: 26667053 [TBL] [Abstract][Full Text] [Related]
27. Comparative structural and evolutionary analyses predict functional sites in the artemisinin resistance malaria protein K13. Coppée R; Jeffares DC; Miteva MA; Sabbagh A; Clain J Sci Rep; 2019 Jul; 9(1):10675. PubMed ID: 31337835 [TBL] [Abstract][Full Text] [Related]
30. Clinical and molecular surveillance of artemisinin resistant falciparum malaria in Myanmar (2009-2013). Nyunt MH; Soe MT; Myint HW; Oo HW; Aye MM; Han SS; Zaw NN; Cho C; Aung PZ; Kyaw KT; Aye TT; San NA; Ortega L; Thimasarn K; Bustos MDG; Galit S; Hoque MR; Ringwald P; Han ET; Kyaw MP Malar J; 2017 Aug; 16(1):333. PubMed ID: 28806957 [TBL] [Abstract][Full Text] [Related]
31. No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China-Myanmar border. Huang F; Shrestha B; Liu H; Tang LH; Zhou SS; Zhou XN; Takala-Harrison S; Ringwald P; Nyunt MM; Plowe CV Malar J; 2020 Sep; 19(1):334. PubMed ID: 32928233 [TBL] [Abstract][Full Text] [Related]
32. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Mbengue A; Bhattacharjee S; Pandharkar T; Liu H; Estiu G; Stahelin RV; Rizk SS; Njimoh DL; Ryan Y; Chotivanich K; Nguon C; Ghorbal M; Lopez-Rubio JJ; Pfrender M; Emrich S; Mohandas N; Dondorp AM; Wiest O; Haldar K Nature; 2015 Apr; 520(7549):683-7. PubMed ID: 25874676 [TBL] [Abstract][Full Text] [Related]
33. Assessment of Plasmodium falciparum Artemisinin Resistance Independent of Nima MK; Mukherjee A; Sazed SA; Hossainey MRH; Phru CS; Johora FT; Safeukui I; Saha A; Khan AA; Marma ASP; Ware RE; Mohandas N; Calhoun B; Haque R; Khan WA; Alam MS; Haldar K mBio; 2022 Feb; 13(1):e0344421. PubMed ID: 35073756 [TBL] [Abstract][Full Text] [Related]
34. Evidence of Artemisinin-Resistant Plasmodium falciparum Malaria in Eastern India. Das S; Saha B; Hati AK; Roy S N Engl J Med; 2018 Nov; 379(20):1962-1964. PubMed ID: 30428283 [No Abstract] [Full Text] [Related]
35. Multi-omics dissection of stage-specific artemisinin tolerance mechanisms in Kelch13-mutant Plasmodium falciparum. Chen J; Gao P; Xiao W; Cheng G; Krishna S; Wang J; Wong YK; Wang C; Gu L; Yang DH; Wang J Drug Resist Updat; 2023 Sep; 70():100978. PubMed ID: 37385107 [TBL] [Abstract][Full Text] [Related]
36. Insights into the intracellular localization, protein associations and artemisinin resistance properties of Plasmodium falciparum K13. Gnädig NF; Stokes BH; Edwards RL; Kalantarov GF; Heimsch KC; Kuderjavy M; Crane A; Lee MCS; Straimer J; Becker K; Trakht IN; Odom John AR; Mok S; Fidock DA PLoS Pathog; 2020 Apr; 16(4):e1008482. PubMed ID: 32310999 [TBL] [Abstract][Full Text] [Related]
37. Ring stage dormancy of Plasmodium falciparum tolerant to artemisinin and its analogues - A genetically regulated "Sleeping Beauty". Auparakkitanon S; Wilairat P Int J Parasitol Drugs Drug Resist; 2023 Apr; 21():61-64. PubMed ID: 36708651 [TBL] [Abstract][Full Text] [Related]
38. Natural selection of K13 mutants of Plasmodium falciparum in response to artemisinin combination therapies in Thailand. Putaporntip C; Kuamsab N; Kosuwin R; Tantiwattanasub W; Vejakama P; Sueblinvong T; Seethamchai S; Jongwutiwes S; Hughes AL Clin Microbiol Infect; 2016 Mar; 22(3):285.e1-8. PubMed ID: 26548510 [TBL] [Abstract][Full Text] [Related]
39. Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018). Raman J; Kagoro FM; Mabuza A; Malatje G; Reid A; Frean J; Barnes KI Malar J; 2019 Aug; 18(1):280. PubMed ID: 31438951 [TBL] [Abstract][Full Text] [Related]
40. Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa? Foguim Tsombeng F; Gendrot M; Robert MG; Madamet M; Pradines B Malar J; 2019 Aug; 18(1):285. PubMed ID: 31443646 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]